Pharmaceutical Company CEO Developing $100 Alternative To EpiPen After 'Shameful' Price Hike
September 4, 2016
Mark Baum, CEO of Imprimis Pharmaceuticals who previously came out with a $1 alternative to Martin Shkreli's AIDS drug after 5000% price hike, is now going to take on Mylan and is plotting to offer a $100 EpiPen alternative.
Mark Baum / Imprimis Pharmceuticals
Baum believes the relentless EpiPen price hikes are "shameful" and plans to have a compounded version of the allergy treatment by the end of the year.
"I don't need to make $19 million a year," Baum said, referring to the big pay package Mylan's CEO Heather Bresch took home last year.
"Tonight when I go home I'm going to eat a nice piece of fish and the fish I eat isn't any better or worse than what she is going to eat."
Click Here For The Most Popular On Sunny Skyz
WOW! Seal Begs Boaters For Help As Orcas Hunt Him
Mom Shares 4th Grader's Spelling Test Answers, #13 Has Everyone Laughing
These Twin Cats Do Everything Together — And We Can’t Get Enough
Cat Goes Viral For Playing Cards Against Humanity — And She’s Serving Pure Chaos
Toddler ‘Arrested’ After Taking One Bite Out Of Every Fruit
The Batman Effect: A Study Shows People Gave Up Their Seats Just Because He Was There
Drone Stumbles Upon Polar Bears Living Their Best Life In Abandoned Soviet Research Station
Mom Catches Dad–Daughter Moment On Baby Monitor And Starts Sobbing
Toddler’s Wholesome Reaction To Dad Being 'Left Out' Goes Viral
100 Musicians Surprise Paris Crowd With The Biggest 'Carol of the Bells' Flashmob Ever
Young Hippo Mistakes Crocodile For A Pillow
